INVOLVEMENT OF PLATELET ACTIVATING FACTOR IN RESPIRATORY ANAPHYLAXIS, DEMONSTRATED BY PAF-ACETHER INHIBITOR BN 52021
暂无分享,去创建一个
[1] G. Nenci,et al. PLATELETS AND ASTHMA , 1985, The Lancet.
[2] J. Gomez-Cambronero,et al. Synthesis of PAF-acether and blood volume changes in gram-negative sepsis. , 1985, Immunopharmacology.
[3] C. Forbes,et al. PLATELETS IN ASTHMA , 1984, The Lancet.
[4] C. Page,et al. THE PLATELET IN ASTHMA , 1984, The Lancet.
[5] B. Vargaftig,et al. The platelet‐independent release of thromboxane A2 by Paf‐acether from guinea‐pig lungs involves mechanisms distinct from those for leukotriene , 1984, British journal of pharmacology.
[6] A. Denjean,et al. Acute effects of intratracheal administration of platelet-activating factor in baboons. , 1983, Journal of applied physiology: respiratory, environmental and exercise physiology.
[7] B. Vargaftig,et al. Inhibition by sulphinpyrazone of the platelet-dependent bronchoconstriction due to platelet-activating factor (PAF-acether) in the guinea pig. , 1981, European journal of pharmacology.
[8] B. Vargaftig,et al. BACKGROUND AND PRESENT STATUS OF RESEARCH ON PLATELET‐ACTIVATING FACTOR (PAF‐ACETHER) , 1981, Annals of the New York Academy of Sciences.